FilingReader Intelligence
Shen Lian Biomedical shares surge over 30%
August 19, 2025 at 05:00 AM UTC•By FilingReader AI
Shen Lian Biomedical's shares rose over 30% across three trading days ending August 18, 2025. The company said operations remain normal with no undisclosed major events.
The company highlighted risks from the long development cycle and high risk associated with innovative drug research by associate company Yangzhou Shizhiyuan Biotechnology.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
SSE:688098•Shanghai Stock Exchange
Animal Health
News Alerts
Get instant email alerts when Shanghai Shen Lian Biomedical Corporation publishes news
Free account required • Unsubscribe anytime